Elancourt, France

Frederic Demonchy

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cellprothera. Active years: 2020.


% Patents Active = 100.0



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frederic Demonchy: Innovator in Automated Cell Culture Technology

Introduction

Frederic Demonchy is a notable inventor based in Elancourt, France. He has made significant contributions to the field of biotechnology, particularly in the area of automated cell culture systems. His innovative approach aims to enhance the efficiency and effectiveness of cell culture processes.

Latest Patents

Frederic holds a patent for an "Automated apparatus and method of cell culture." This invention provides an automated apparatus that includes tanks for culture medium, growth factors, and cells to be cultured. The system features an incubator with a thermostated enclosure that houses a cell culture vessel, along with a control computer system. Additionally, it incorporates a supporting and agitation device for the culture vessel, which is designed as a bag with multiple ports for connection to external harvesting and storage devices.

Career Highlights

Frederic is currently associated with Cellprothera, a company focused on advancing cell therapy technologies. His work has been instrumental in developing automated solutions that streamline the cell culture process, making it more accessible and efficient for research and therapeutic applications.

Collaborations

Frederic collaborates with talented professionals in his field, including Philippe Henon and Claire Saucourt. Their combined expertise contributes to the innovative projects at Cellprothera, fostering advancements in biotechnology.

Conclusion

Frederic Demonchy's contributions to automated cell culture technology exemplify the impact of innovation in biotechnology. His patent and ongoing work at Cellprothera highlight the importance of automation in enhancing cell culture processes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…